Attenuation of doxorubicin-induced cardiotoxicity and genotoxicity by an indole-based natural compound 3,3′-diindolylmethane (DIM) through activation of Nrf2/ARE signaling pathways and inhibiting apoptosis

References

• Carvalho C, Santos RX, Cardoso S, Correia S, Oliveira PJ, Santos MS, et al. Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem 2009;16:3267–3285.
   PubMed Web of Science ®Google Scholar
• Bast A, Kaiserová H, den Hartog G, Haenen G. Vijgh1 W. Protectors against doxorubicin induced cardiotoxicity: flavonoids. Cell Biol Toxicol 2007;23:39–47.
   PubMed Web of Science ®Google Scholar
• Mertens AC, Yasui Y, Neglia JP, Potter JD, Nesbit ME Jr, Ruccione K, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol 2001;19:3163–3172.
   PubMed Web of Science ®Google Scholar
• Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stovall M, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 2009;339:b4606.
   PubMed Web of Science ®Google Scholar
• Singal PK, Li T, Kumar D, Danelisen I, Iliskovic N. Adriamycin-induced heart failure: mechanism and modulation. Mol Cell Biochem 2000;207:77–86.
   PubMed Web of Science ®Google Scholar
• Leite-Silva C, Gusmão CLS, Takahashi CS. Genotoxic and antigenotoxic effects of Fucus vesiculosus extract on cultured human lymphocytes using the chromosome aberration and comet assays. Genet Mol Biol 2007;30:105–111.
   Web of Science ®Google Scholar
• Fedato RP, Maistro EL. Absence of genotoxic effects of the coumarin derivative 4-methylesculetin in vivo and its potential chemoprevention against doxorubicin-induced DNAdamage. J Appl Toxicol 2014;34:33–39.
   PubMed Web of Science ®Google Scholar
• Tolentino F, Araújo PA, Marques Ede S Petreanu M, Andrade SF, Niero R, et al. In vivo evaluation of the genetic toxicity of Rubus niveus Thunb. (Rosaceae) extract and initial screening of its potential chemoprevention against doxorubicin-induced DNA damage. J Ethnopharmacol 2015;164:89–95.
   PubMed Web of Science ®Google Scholar
• Argun M, Üzüm K, Sönmez MF, Özyurt A, Derya K, Çilenk KT, et al. Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats. Anatol J Cardiol 2016;16:234–241.
   PubMed Web of Science ®Google Scholar
• Menna P, Minotti G, Salvatorelli E. In vitro modeling of the structure-activity determinants of anthracycline cardiotoxicity. Cell Biol Toxicol 2007;23:49–62.
   PubMed Web of Science ®Google Scholar
• Olson RD, Mushlin PS, Brenner DE, Fleischer S, Cusack BJ, Chang BK, et al. Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol. Proc Natl Acad Sci U S A 1988;85:3585–3589.
   PubMed Web of Science ®Google Scholar
• Amara-Mokrane YA, Lehucher-Michel MP, Balansard G, Dumenil G, Botta A. Protective effects of alpha-hederin, chlorophillin and ascorbic acid towards the induction of micronuclei by doxorubicin in cultured human lymphocytes. Mutagenesis 1996;11:161–167.
   PubMed Web of Science ®Google Scholar
• Ludke A, Sharma AK, Bagchi AK, Singal PK. Subcellular basis of vitamin C protection against doxorubicin-induced changes in rat cardiomyocytes. Mol Cell Biochem 2012;360:215–224.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM, Snader KM. Natural products as sources of new drugs over the period 1981–2002. J Nat Prod 2003;66:1022–1037.
   PubMed Web of Science ®Google Scholar
• Herr I, Büchler MW. Dietary constituents of broccoli and other cruciferous vegetables: implications for prevention and therapy of cancer. Cancer Treat Rev 2010;36:377–383.
   PubMed Web of Science ®Google Scholar
• De Kruif CA, Marsman JW, Venekamp JC, Falke HE, Noordhoek J, Blaauboer BJ, et al. Structure elucidation of acid reaction products of indole-3-carbinol: detection in vivo and enzyme induction in vitro. Chem Biol Interact 1991;80:303–315.
   PubMed Web of Science ®Google Scholar
• Grubbs CJ, Steele VE, Casebolt T, Juliana MM, Eto I, Whitaker LM, et al. Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res 1995;15:709–716.
   PubMed Web of Science ®Google Scholar
• Bailey GS, Dashwood RH, Fong AT, Williams DE, Scanlan RA, Hendricks JD. Modulation of mycotoxin and nitrosamine carcinogenesis by indole-3-carbinol: quantitative analysis of inhibition versus promotion. IARC Sci Publ 1991;105:275–280.
   Google Scholar
• Kojima T, Tanaka T, Mori H. Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol. Cancer Res 1994;54:1446–1449.
   PubMed Web of Science ®Google Scholar
• Morse MA, LaGreca SD, Amin SG, Chung FL. Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice. Cancer Res 1990;50:2613–2617.
   PubMed Web of Science ®Google Scholar
• Shertzer HG, Tabor MW, Hogan IT, Brown SJ, Sainsbury M. Molecular modeling parameters predict antioxidant efficacy of 3-indolyl compounds. Arch Toxicol 1996;70:830–834.
   PubMed Web of Science ®Google Scholar
• Arnao MB, Sanchez-Bravo J, Acosta M. Indole-3-carbinol as a scavenger of free radicals. Biochem Mol Biol Int 1996;39:1125–1134.
   PubMedGoogle Scholar
• Organization for Economic Cooperation and Development. Acute oral toxicity: up-and-down procedure. In: OECD guidelines for the testing of chemicals, guideline No. 425. Paris: OECD Publishing; 2008.
   Google Scholar
• D’Armour FE, Blood FR, Belden DA. The manual for laboratory work in mammalian physiology. 3rd ed. Chicago (IL): The University of Chicago Press; 1965. p. 4–6.
   Google Scholar
• Wintrobe MM, Lee GR, Boggs DR, Bithel TC, Athens JW, Foerester J. Clinical hematology. 5th ed. Philadelphia (PA): Lea and Febiger; 1961. p. 326.
   Google Scholar
• Bhattacharjee A, Basu A, Ghosh P, Biswas J, Bhattacharya S. Protective effect of selenium nanoparticle against cyclophosphamide induced hepatotoxicity and genotoxicity in Swiss albino mice. J Biomater Appl 2014;29:303–317.
   PubMed Web of Science ®Google Scholar
• Basu A, Singha Roy S, Bhattacharjee A, Bhuniya A, Baral R, Biswas J, et al. Vanadium(III)-L-cysteine protects cisplatin-induced nephropathy through activation of Nrf2/HO-1 pathway. Free Radic Res 2016;50:39–55.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–275.
   PubMed Web of Science ®Google Scholar
• Bancroft JD, Stevens A, Turner DR. Theory and practice of histological techniques. 3rd ed. Great Britain: Longman Group UK Limited; 1990. p. 148–189.
   Google Scholar
• Ghosh P, Singha Roy SS, Basu A, Bhattacharjee A, Bhattacharya S. Sensitization of cisplatin therapy by a naphthalimide based organoselenium compound through modulation of antioxidant enzymes and p53 mediated apoptosis. Free Radic Res 2015;49:453–471.
   PubMed Web of Science ®Google Scholar
• Ellwart J, Dörmer P. Effect of 5-fluoro-2’-deoxyuridine (FdUrd) on 5-bromo-2’-deoxyuridine (BrdUrd) incorporation into DNA measured with a monoclonal BrdUrd antibody and by the BrdUrd/Hoechst quenching effect. Cytometry 1985;6:513–520.
   PubMedGoogle Scholar
• Preston RJ, Dean BJ, Galloway S, Holden H, McFee AF, Shelby M. Mammalian in vivo cytogenetic assays. Analysis of chromosome aberrations in bone marrow cells. Mutat Res 1987;189:157–165.
   PubMed Web of Science ®Google Scholar
• Klein CB, Broday L, Costa M. Assays for detecting chromosomal aberrations. Curr Protoc Toxicol 2001;3:3.3.
   Google Scholar
• Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;175:184–191.
   PubMed Web of Science ®Google Scholar
• Zhivotovsky B, Samali A, Orrenius S. Determination of apoptosis and necrosis. Curr Protoc Toxicol 2001;Chapter(2):Unit 2.2.
   Google Scholar
• Hui MK, Wu WK, Shin VY, So WH, Cho CH. Polysaccharides from the root of Angelica sinensis protect bone marrow and gastrointestinal tissues against the cytotoxicity of cyclophosphamide in mice. Int J Med Sci 2006;3:1–6.
   PubMedGoogle Scholar
• Tallaj JA, Franco V, Rayburn BK, Pinderski L, Benza RL, Pamboukian S, et al. Response of doxorubicin-induced cardiomyopathy to the current management strategy of heart failure. J Heart Lung Transplant 2005;24:2196–2201.
   PubMed Web of Science ®Google Scholar
• Li L, Pan Q, Han W, Liu Z, Li L, Hu X. Schisandrin B prevents doxorubicin-induced cardio toxicity via enhancing glutathione redox cycling. Clin Cancer Res 2007;13:6753–6760.
   PubMed Web of Science ®Google Scholar
• Doroshow JH, Locker GY, Myers CE. Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin. J Clin Invest 1980;65:128–135.
   PubMed Web of Science ®Google Scholar
• Nohl H, Gille L, Staniek K. The exogenous NADH dehydrogenase of heart mitochondria is the key enzyme responsible for selective cardiotoxicity of anthracyclines. Z Naturforsch C 1998;53:279–285.
   PubMed Web of Science ®Google Scholar
• Zhang YW, Shi J, Li YJ, Wei L. Cardiomyocyte death in doxorubicin-induced cardiotoxicity. Arch Immunol Ther Exp (Warsz) 2009;57:435–445.
   PubMed Web of Science ®Google Scholar
• Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 2004;56:185–229.
   PubMed Web of Science ®Google Scholar
• Takemura G, Fujiwara H. Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Prog Cardiovasc Dis 2007;49:330–352.
   PubMed Web of Science ®Google Scholar
• Matouk AI, Taye A, Heeba GH, El-Moselhy MA. Quercetin augments the protective effect of losartan against chronic doxorubicin cardiotoxicity in rats. Environ Toxicol Pharmacol 2013;36:443–450.
   PubMed Web of Science ®Google Scholar
• Mantawy EM, El-Bakly WM, Esmat A, Badr AM, El-Demerdash E. Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis. Eur J Pharmacol 2014;728:107–118.
   PubMed Web of Science ®Google Scholar
• Harake D, Franco VI, Henkel JM, Miller TL, Lipshultz SE. Cardiotoxicity in childhood cancer survivors: strategies for prevention and management. Future Cardiol 2012;8:647–670.
   PubMedGoogle Scholar
• Reddy PN, Reddy PS, Rao MR. Studies on the effect of doxorubicin on MDA, NO2, NO3, Se-GSH peroxidase and SOD levels in albino rat tissues. Afr J Biotechnol 2007;6:2303–2309.
   Google Scholar
• Narin F, Demir F, Akgün H, Baykan A, Uzum K, Kuzuguden S, et al. Doxorubicin-induced experimental cardiotoxicity and effect of pentoxphylline on cardiotoxicity. Arch Turk Soc Cardiol 2004;32:279–287.
   Google Scholar
• Tacar O, Sriamornsak P, Dass CR. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 2013;65:157–170.
   PubMed Web of Science ®Google Scholar
• Groopman JE, Itri LM. Chemotherapy-induced anemia in adults: incidence and treatment. J Natl Cancer Inst 1999;91:1616–1634.
   PubMed Web of Science ®Google Scholar
• Rejitha S, Prathibha P, Indira M. Nrf2-mediated antioxidant response by ethanolic extract of Sida cordifolia provides protection against alcohol-induced oxidative stress in liver by upregulation of glutathione metabolism. Redox Rep 2015;20:75–80.
   PubMed Web of Science ®Google Scholar
• Chen C, Kong AN. Dietary chemopreventive compounds and ARE/EpRE signaling. Free Radic Biol Med 2004;36:1505–1516.
   PubMed Web of Science ®Google Scholar
• Attia SM, Bakheet SA. Effect of dihydrokainate on the capacity of repair of DNA damage and apoptosis induced by doxorubicin. Mutagenesis 2013;28:257–261.
   PubMed Web of Science ®Google Scholar
• Dhawan A, Kayani MA, Parry JM, Parry E, Anderson D. Aneugenic and clastogenic effects of doxorubicin in human lymphocytes. Mutagenesis 2003;18:487–490.
   PubMed Web of Science ®Google Scholar
• Gülkac MD, Akpinar G, Ustün H, Kanli AO. Effects of vitamin A on doxorubicin-induced chromosomal aberrations in bone marrow cells of rats. Mutagenesis 2004;19:231–236.
   PubMed Web of Science ®Google Scholar
• Islaih M, Halstead BW, Kadura IA, Li B, Reid-Hubbard JL, Flick L, et al. Relationships between genomic, cell cycle, and mutagenic responses of TK6 cells exposed to DNA damaging chemicals. Mutat Res 2005;578:100–116.
   PubMed Web of Science ®Google Scholar
• Antunes LM, Takahashi CS. Effects of high doses of vitamins C and E against doxorubicin induced chromosomal damage in Wistar rat bone marrow cells. Mutat Res 1998;419:137–143.
   PubMed Web of Science ®Google Scholar
• Kyrylkova K, Kyryachenko S, Leid M, Kioussi C. Detection of apoptosis by TUNEL assay. Methods Mol Biol 2012;887:41–47.
   PubMedGoogle Scholar
• Niture SK, Jaiswal AK. Nrf2-induced anti-apoptotic Bcl-xL protein enhances cell survival and drug resistance. Free Radic Biol Med 2013;57:119–131.
   PubMed Web of Science ®Google Scholar